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ABSTRACT
Background. Complications after surgical stabilization
for the treatment of unstable spinal metastases are com-
mon. Less invasive surgical (LIS) procedures are
potentially associated with a lower risk of complications;
however, little is known regarding the complications after
LIS procedures for the treatment of spinal metastases. Our
primary objective was to determine the characteristics and
rate of complications after percutaneous pedicle screw
fixation (PPSF) for the treatment of mechanically unsta-
ble spinal metastases. The secondary objective was to
identify factors associated with the occurrence of compli-
cations and survival.
Methods. A retrospective multicenter cohort study of
patients who underwent PPSF between 2009 and 2014 for
the treatment of unstable spinal metastases was performed.
Patient data pertaining to demographics, diagnosis, treat-
ment, neurologic function, complications, and survival
were collected.
Results. A total of 101 patients were identified, 45 men
(45 %) and 56 women (55 %) with a mean age of
60.3 ± 11.2 years. The median operating time was 122
(range 57–325) minutes with a median blood loss of 100 ml
(based on 41 subjects). Eighty-eight patients (87 %)
ambulated within the first 3 days after surgery. An overall
median survival of 11.0 (range 0–70) months was observed,
with 79 % of the patients alive at 3 months after treatment.
Eighteen patients experienced a total of 30 complications;
nonsurgical complications were the most commonly
encountered. Prolonged operating time was independently
associated with an increased risk of complications.
Conclusions. A complication rate of 18 % was found after
PPSF for unstable spinal metastases. Potential advantages
of less invasive treatment are limited blood loss and high
early ambulation rate.
The life expectancy of patients diagnosed with meta-
static disease can vary from several weeks or months for
patients with unfavorable aggressive primary tumors with
bone and visceral involvement to several years for patients
with exclusively bone metastases, with the spinal column
being the most common location for bone metastases.1–3
Radiotherapy has been the standard of care for the treat-
ment of symptomatic spinal metastases.4,5 However, if
spinal metastases compromise the mechanical integrity of
the spine, surgical stabilization is the preferred treatment
option, followed by radiotherapy for local tumor control.6
Surgical stabilization has traditionally been performed
through open procedures necessitating extensive soft tissue
dissection associated with significant blood loss, lengthy
hospital stays, and a substantial risk of complications.7
Invasive procedures are—considering the limited life
expectancy and comorbidities of most patients with spinal
metastases—often undesirable and unfeasible.8
Advancements in surgical techniques have led to the
development of the concept of less invasive surgical (LIS)
procedures with the aim of achieving the same clinical
results with less morbidity related to surgical approach.8
Benefits of less invasive techniques include decreased blood
loss, less postoperative pain, and shortened recovery time.8
Moreover, LIS procedures allow earlier initiation of
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postoperative adjuvant treatments due to faster wound
healing.9 The ability to perform LIS procedures for the
treatment of unstable spinal metastases may enable sur-
geons to offer surgical intervention to patients who were not
deemed to be candidates for conventional open surgery.8
LIS procedures have been shown to be safe and have
resulted in good clinical outcomes in patients with trau-
matic and degenerative spinal disorders.10–12 Only a few
studies have investigated the clinical outcome of less
invasive techniques for the treatment of spinal metastases,
with improved pain scores and functional status being
reported.13–16 However, a paucity of literature exists
regarding the safety of less invasive surgery for the treat-
ment of symptomatic spinal metastases. Therefore, the
primary objective of this study was to determine the
characteristics and rate of complications after percutaneous
pedicle screw fixation (PPSF) for the treatment of
mechanically unstable spinal metastases. The secondary
objective was to identify factors associated with the
occurrence of complications and survival.
METHODS
A multicenter retrospective observational cohort study
of patients who underwent PPSF for the treatment of
unstable spinal metastases was performed. The local
institutional review board approved the research protocol.
Patients were eligible for inclusion if they had histologic
proof of malignancy (including multiple myeloma) and
were treated with PPSF, with or without cement augmen-
tation, between January 2009 and December 2014. An
(impending) unstable pathologic fracture and/or
intractable mechanical pain due to an impending patho-
logic fracture were indications for surgical intervention. In
addition, a life expectancy of at least 3 months, as assessed
by the referring oncologist, was required. Assessment of
the degree of spinal instability was based on the clinical
experience of the surgeon and/or the recent spinal insta-
bility neoplastic score.17 To enhance the homogeneity of
the procedure and study population, patients were excluded
if they were diagnosed with a primary spinal tumor or if
additional minimal-access spine surgery (e.g., mini open
decompression, laminectomy) was performed.
Data pertaining to demographics, primary tumor diag-
nosis, surgical treatment, neurologic status, performance
status, complications, and survival were collected from
medical charts and institutional databases. Government
databases were accessed to retrieve information about vital
statistics. The definitions and scales of the outcome
parameters are listed in Table 1.
Continuous data were described using mean, median,
standard deviation, and range. Frequencies were used to
describe categorical data. Univariate logistic regression
was performed to identify predictive factors for the
occurrence of complications. Linear regression analysis
was conducted to determine variables related to length of
stay. The Kaplan–Meier analysis and log-rank tests were
used to investigate factors that influenced survival, fol-
lowed by multivariate Cox regression analysis to determine
the impact of the variables. P\ 0.05 defined significance.
IBM SPSS Statistics 21.0 for Windows was used for the
analysis (IBM, Armonk, NY, USA).
RESULTS
Demographics
A total of 101 patients were identified in the five par-
ticipating centers; 45 patients were male (45 %) and 56
were female (55 %), and mean age was 60.3 ± 11.2 years.
Patient characteristics are listed in Table 2. Breast cancer
(25 %) and multiple myeloma (25 %) were the most fre-
quent primary tumors. Fifty percent of the patients had
exclusively metastatic bone disease, 42 % had bone and
visceral metastases, and the remaining 8 % had bone and
lymph node metastases. Ninety-four of the patients (93 %)
were neurologically intact before surgery [American Spinal
Injury Association (ASIA) E], six patients (6 %) had min-
imal motor impairment (ASIA D) without progression, and
one patient (1 %) had severe motor impairment (ASIA C).
Operative Characteristics
Median time from first surgical consultation to surgical
intervention was 9 (range 0–377) days. The most com-
monly treated areas were the thoracolumbar (T10–L2,
n = 39) and thoracic (n = 38) regions, followed by the
lumbar (n = 22) and lumbosacral (L4–S2, n = 2) regions.
The median operating time was 122 (range 57–325) min-
utes; median blood loss was 100 (range 50–500) ml based
on data available for 41 patients. Five or more vertebral
bodies were bridged in 65 patients (64 %), four in nine
patients (9 %), and three in 27 patients (27 %). Vertebro-
plasty was performed in six patients (6 %), kyphoplasty in
10 patients (10 %), and vertebral body stenting in 19
patients (19 %). Cement augmentation of pedicle screws
was performed in three patients (3 %).
Eighty-seven percent of the patients (n = 88) were
ambulatory within the first 3 days after surgery (median
1 day), and overall median length of hospital stay was 7
(range 1–43) days. Patients who experienced a complication
had a median length of hospital stay of 11.5 days, which was
significantly longer compared to a median length of hospital
stay of 7 days for patients without complications
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(P = 0.002). The overall presence of complications
(P = 0.003), the need for reoperation (P\ 0.001), the
presence of neurologic deterioration (P = 0.015), the pres-
ence of construct failure (P\ 0.001), and the presence of
nonsurgical complications (P = 0.026) were associated
with increased length of hospital stay. The most common
form of adjuvant treatment was postoperative radiotherapy
in 56 patients (55 %). Fifteen patients (15 %) had received
radiotherapy before surgery, 11 patients (11 %) received
both pre- and postoperative radiotherapy, and 17 patients
(16 %) did not receive additional radiotherapy.
Complications
A total of 30 complications occurred (Table 3), with 18
patients experiencing at least one complication. Prolonged
operating time (P = 0.041) was the only factor signifi-
cantly associated with the occurrence of complications.
Nonsurgical adverse events were common, including
delirium (n = 3), pneumonia (n = 2), ileus (n = 1), uri-
nary tract infection (n = 1), and bladder retention (n = 1).
Furthermore, one patient developed a perioperative acute
coronary syndrome. This patient was transported to the
intensive care unit after surgery and died 3 days later of
cardiac failure.
A wound-healing disturbance occurred in four patients;
two of these were deep wound infections. Four patients
experienced construct failure; two patients had a pedicle
screw pullout, with one of the two patients requiring a
reoperation; and one patient had a broken pedicle screw
(S1), causing pain and requiring reoperation 1.5 years after
the index surgery. In one patient, secondary screw pullout
occurred as a result of tumor progression, which required
revision surgery within 1 month of the index surgery. After
the second surgery, the patient developed a superficial
wound infection and experienced neurologic deterioration
due to tumor growth into the spinal canal; neither preop-
erative nor postoperative radiotherapy was administered.
Local tumor progression was also the cause for neurologic
deterioration in two other patients, both within 4 months
TABLE 1 Definitions of outcome parameters
Parameter Definition Scale/unit Time points
Neurologic status Degree of neurologic deficit ASIA scale24 Pre- and postoperative,
first follow-up visit
Performance status Level of daily functioning Karnofsky25 Preoperative
Consultation time Time from first surgical consultation until date of surgery Days NA
Ambulatory function Able to walk at least 4 steps20 Days NA
Blood loss Estimated blood loss Milliliters NA
Complication Any unexpected and undesirable medical event that required
additional intervention or monitoring
NA Peri- and postoperative
Operating time Time from first incision until wound closure (‘‘skin to skin’’) Minutes NA
Hospital stay Date of surgery until date of discharge Days NA
Follow-up time Date of surgery until date of death Months NA
ASIA American Spinal Injury Association
TABLE 2 Baseline characteristics
Characteristic Value
Gender (n = 101)
Female 56 (55 %)
Male 45 (45 %)
Age at surgery, years (n = 101) 60.3 (SD 11.2)
Primary tumor type (n = 101)
Breast 25 (25 %)
Multiple myeloma 25 (25 %)
Lung 13 (13 %)
Kidney 10 (10 %)
Prostate 5 (5 %)
Other 23 (22 %)
Clinical presentation (n = 101)
Back pain 53 (52 %)
Radicular pain 7 (7 %)
Combined radicular and back pain 20 (20 %)
Impending fracture without significant pain 21 (21 %)
Karnofsky performance status (n = 98)
100 % 4 (4 %)
80–90 % 46 (47 %)
60–70 % 28 (28 %)
40–50 % 20 (21 %)
\30 % 0 (0 %)
Preoperative ASIA scale (n = 101)
E 94 (93 %)
D 6 (6 %)
A/B/C 1 (1 %)
ASIA American Spinal Injury Association
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after index surgery. Neurologic deterioration also occurred
in two other patients; one experienced permanent complete
paraplegia resulting from medial placement of a pedicle
screw, and revision surgery was performed without post-
operative neurologic improvement. Cement extravasation
resulting in an incomplete spinal cord lesion (ASIA C),
from which the patient recovered fully (ASIA E) after
reoperation, was the cause in the other patient. A total of
six patients (7 %) required revision surgery. One patient
experienced transient neurologic deterioration immediately
after surgery at the recovery unit but recovered sponta-
neously within 6 h. Neurologic status over time is
displayed in Table 4.
Survival
The overall median survival was 11.0 (range 0–70)
months, with 39 patients (39 %) still alive in March 2015.
Seventy-nine patients (78 %) were alive 3 months after
surgery. Kaplan–Meier analysis revealed that patients with
breast carcinoma and multiple myeloma had significantly
better survival compared to other primary tumor types
(Fig. 1). Univariate analysis demonstrated that lower per-
formance status (P = 0.043), primary tumor type
(P\ 0.001), presence of node and/or organ metastases
(P = 0.019), and no administration of postoperative
chemotherapy (P = 0.007) negatively influenced 3-month
survival. Using multivariate analysis only, the lack of
administration of postoperative chemotherapy [P = 0.017,
hazard ratio (HR) 5.8, 95 % confidence interval (CI) 1.79–
18.77] was demonstrated to be independently associated
with mortality within 3 months after surgery.
Overall survival was negatively influenced by older age
(P\ 0.001), primary tumor type (P\ 0.001), and the
presence of node and/or or visceral metastases (P\ 0.001)
in the univariate analysis. Multivariate analyses demon-
strated that two factors were independently associated with
impaired overall survival: a diagnosis of primary tumor
type other than breast, prostate, lung, or renal carcinoma
(P = 0.006, HR 3.94, 95 % CI 1.4–8.1), and the presence
of lymph node and/or visceral metastases (P\ 0.005, HR
2.9, 95 % CI 1.37–6.1).
DISCUSSION
Advancements in surgical techniques and implants have
led to the development of LIS procedures. Thus far, studies
reporting the clinical outcomes after minimally invasive
procedures for the treatment of spinal metastases have been
few.13–16 These studies reported promising clinical results
in terms of decreased postoperative pain levels and early
recovery of ambulatory function.13–16 To our knowledge,
we present the largest cohort of patients who underwent
PPSF, with or without cement augmentation, for the
treatment of spinal metastases, and the first study with a
specific focus on the characteristics and rate of complica-
tions. In addition, factors that could predict the occurrence



































FIG. 1 Kaplan–Meier survival curve. Differences in survival
between different tumor types were tested by log-rank test,
P\ 0.001. Excluding multiple myeloma, P\ 0.001
TABLE 3 Complications in 101 patients
Complication n (%)
Superficial wound infection 2 (2)
Deep wound infection 2 (2)
Neurologic deterioration
Transient deterioration 1 (1)
Surgical permanent deterioration 2 (2)
Secondary permanent deterioration 3 (3)
Construct failure
Within 3 months 1 (1)
After 3 months 3 (3)
Malposition of screw 1 (1)
Reoperation 6 (6)
Other complications 9 (9)
TABLE 4 Neurologic status over time
ASIA score Preoperative Postoperative Follow-upa
E 94 94 93
D 6 3 3
C 1 1 1
B 0 1 1
A 0 1 1
ASIA American Spinal Injury Association
a One patient died in hospital; last neurologic function was
postoperative
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This study demonstrated that 18 % of the patients
experienced at least one complication, with an increased
risk for complications with longer operation duration.
Seven patients required revision surgery for construct
failure, neurologic deterioration, or surgical debridement of
a deep wound infection. Two different studies reporting on
outcomes after PPSF, but without specific focus on com-
plications, reported complication rates of 9 % (4 of 46) and
17 % (2 of 12).13,14 In comparison, several retrospective
studies have investigated complications rates after open
surgical procedures for the treatment of spinal metastases,
with complication rates reported between 15 and 47 %.7
Furthermore, Dea et al. conducted a prospective study on
adverse events after emergency spine surgery for spinal
metastases.7 A complication rate of 76 % was found, with a
mean of 1.8 adverse events per patient.7 Both prospective
and retrospective studies report high complication rates
after surgical intervention for spinal metastases.7 The high
risk for complications does not only reflect the surgical
demand of these procedures but also reflects the fragility of
this patient category.18 Our reported complication rate of
18 % falls in the lower range of previously published
complication rates, suggesting that PPSF for the treatment
of spinal metastases may result in fewer complications
compared to conventional open procedures. However, the
retrospective design of this study may also account for this
lower complication rate. Minor complications may not
have been registered in the patient’s medical chart. In
addition, only patients who underwent PPSF were included
for analysis. This limits the direct comparison of compli-
cation rates between different surgical approaches.
However, by including only patients who underwent iso-
lated PPSF, we aimed to create homogeneity regarding the
surgical procedure, thereby facilitating more accurate
interpretation of the complications associated with PPSF.
The multicenter research approach has resulted in a rela-
tively large number of patients, thereby increasing the
generalizability of the results. It should, however, be noted
that PPSF, in regular practice, is also frequently combined
with decompressive techniques as a LIS procedure.
Three (3 %) of our patients experienced neurologic
deterioration caused by local tumor progression. This rate
is similar to other studies reporting decreased ambulatory
and/or neurologic function due to local disease progression
resulting in spinal cord compression.13,14 Although this rate
is relatively low, the impact of this complication on quality
of life is substantial and is also associated with decreased
survival rates.19,20 Symptomatic spinal cord compression is
best treated with the combination of surgical decompres-
sion, stabilization, and radiotherapy.21 PPSF techniques
can successfully be combined with mini open decompres-
sive techniques in patients with symptomatic spinal cord
compression. However, because the benefits of
percutaneous surgical procedures, compared to conven-
tional open techniques, quickly diminish when
decompressive techniques are required as a result of the
increased risk of complications, the presence of symp-
tomatic spinal cord compression may be regarded as a
relative contraindication for PPSF techniques.
Although LIS procedures have potential benefits, there
are also some limitations. First, LIS procedures depend on
accurate intraoperative visualization of the bony anatomy
to minimize the risk of screw malposition and to prevent
cement leakage. Second, the implants used in LIS proce-
dures serve as an internal brace because bony fusion is not
achievable with most LIS procedures.11,16 However, con-
sidering the limited life expectancy of most patients with
spinal metastases, the main goal is to improve quality of
life by stabilizing the spine rather than achieving fusion, as
is the goal with traumatic fractures.16 Third, only limited
sagittal correction can be achieved using current LIS pro-
cedures compared to an open procedure.11 It should be
noted that the term ‘‘LIS procedure’’ does not encompass
one surgical technique but rather is a surgical concept
including a wide variety of surgical procedures, including
minimal-access decompression of the spinal cord.
The most frequent complications in our study were
neurologic deterioration (6 %) and revision surgery (6 %),
with three patients requiring revision surgery as a result of
neurologic deterioration. In contrast, studies reporting on
adverse events after open surgical procedures report
infection (including wound infections), pneumonia, and
hematoma as frequent complications.7,18 Four of our
patients experienced a wound complication consisting of
two deep and two superficial wound infections. No
excessive blood loss or hematomas were reported. The
differences in complication types between open surgical
procedures and percutaneous procedures can be explained
by the difference in surgical approach, with PPSF having
several potential advantages over the open approach. First,
PPSF is performed through small stab incisions. The
combined total length of the incisions may be the same or
longer compared to open surgery, but the smaller incisions
limit soft tissue dissection, minimize blood loss, decrease
postoperative pain, and decrease the risk of wound-healing
disturbances. Less postoperative pain also results in less
analgesics use, earlier ambulation, and shorter hospital
stay. This study reported a median length of hospital stay
of 7 days, and 78 % of the patients were ambulatory within
the first 3 days after surgery. A significant difference was
found between the length of stay of patients with and
without complications. Finally, PPSF is associated with
less blood loss, with a median blood loss of 100 ml in the
present study. Significant blood loss has been associated
with lengthy hospital stays as well as increased morbidity
and mortality rates.8 Furthermore, significant blood loss
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often requires blood transfusions, which are associated
with immunosuppression and a subsequent increased risk
of infection and disease progression.22
Most of the patients who require surgical intervention for
the treatment of spinal metastases are subsequently treated
with radiotherapy for local control. In addition, chemother-
apy and/or immunotherapy are often initiated as systemic
treatment. Improved wound healing caused by the smaller
incisions allows for earlier initiation of postoperative adju-
vant therapies.9 Earlier initiation or continuation of adjuvant
therapies is important in the palliative phase to maximize
tumor control.23 Fewer complications and shortened reha-
bilitation time with LIS procedures may also enable surgical
intervention for patients who were not considered to be good
surgical candidates for extensive open surgery on the bases
of their life expectancy and physical status.8
In conclusion, to our knowledge, this is the first study to
specifically focus on complications after PPSF for the
treatment of spinal metastases. A complication rate of
18 % was found, suggesting that PPSF may lead to fewer
complications compared to complication rates of open
surgical procedures that have been reported in the litera-
ture.7 Prolonged operating time was demonstrated to be
associated with an increased risk of complications. In
addition, the absence of postoperative administration of
chemotherapy was associated with mortality at 3 months
after surgery. Potential advantages of LIS procedures
consist of decreased need for blood transfusions, decreased
need for analgesics, early ambulatory function, shorter
hospital stay, and earlier initiation of postoperative adju-
vant therapies. Future prospective studies are needed to
improve our insight in the frequency and types of com-
plications after different types of LIS procedures.
DISCLOSURE The authors declare no conflict of interest.
OPEN ACCESS This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
REFERENCES
1. Nguyen J, Chow E, Zeng L, et al. Palliative response and func-
tional interference outcomes using the Brief Pain Inventory for
spinal bony metastases treated with conventional radiotherapy.
Clin Oncol. 2011;23:485–91.
2. Bollen L, van der Linden YM, Pondaag W, et al. Prognostic
factors associated with survival in patients with symptomatic
spinal bone metastases: a retrospective cohort study of 1043
patients. Neurooncology. 2014;16:991–8.
3. Falicov A, Fisher CG, Sparkes J, Boyd MC, Wing PC, Dvorak
MF. Impact of surgical intervention on quality of life in patients
with spinal metastases. Spine. 2006;31:2849–56.
4. Gerszten PC, Welch WC. Current surgical management of
metastatic spinal disease. Oncology (Williston Park). 2000;14:
1013–1036.
5. Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone
metastases: an ASTRO evidence-based guideline. Radiat Oncol
Biol. 2011;79:965–76.
6. Laufer I, Rubin DG, Lis E, et al. The NOMS framework:
approach to the treatment of spinal metastatic tumors. Oncologist.
2013;18:744–51.
7. Dea N, Versteeg A, Fisher C, et al. Adverse events in emergency
oncological spine surgery: a prospective analysis. J Neurosurg
Spine. 2014;21:698–703.
8. Molina CA, Gokaslan ZL, Sciubba DM. A systematic review of
the current role of minimally invasive spine surgery in the
management of metastatic spine disease. Int J Surg Oncol.
2011;2011:1–9.
9. Rose PS, Clarke MJ, Dekutoski MB. minimally invasive treat-
ment of spinal metastases: techniques. Radiat Oncol Biol.
2011;2011:1–6.
10. Uribe JS, Deukmedjian AR, Mummaneni PV, et al. Complica-
tions in adult spinal deformity surgery: an analysis of minimally
invasive, hybrid, and open surgical techniques. Neurosurg Focus.
2014;36:E15.
11. Palmisani M, Gasbarrini A, Brodano GB, et al. Minimally inva-
sive percutaneous fixation in the treatment of thoracic and lumbar
spine fractures. Eur Spine J. 2009;18(S1):71–4.
12. 12. Zairi F, Court C, Tropiano P, et al. Minimally invasive
management of thoraco-lumbar fractures: combined percutaneous
fixation and balloon kyphoplasty. Orthop Traumatol Surg Res.
2012;98:S105–11.
13. Moussazadeh N, Rubin D, McLaughlin L, Lis E, Bilsky MH,
Laufer I. Short-segment percutaneous pedicle screw fixation with
cement augmentation for tumor-induced spinal instability. Spine
J. 2015;15:1609–17.
14. Park HY, Lee SH, Park SJ, Kim ES, Lee CS, Eoh W. Minimally
invasive option using percutaneous pedicle screw for instability
of metastasis involving thoracolumbar and lumbar spine: a case
series in a single center. J Korean Neurosurg Soc. 2015;57:100.
15. Kim CH, Chung CK, Sohn S, Lee S, Park SB. Less invasive
palliative surgery for spinal metastases. J Surg Oncol.
2013;108:499–503.
16. Schwab JH, Gasbarrini A, Cappuccio M, et al. Minimally inva-
sive posterior stabilization improved ambulation and pain scores
in patients with plasmacytomas and/or metastases of the spine. Int
J Surg Oncol. 2011;2011:1–5.
17. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification
system for spinal instability in neoplastic disease: an evidence-
based approach and expert consensus from the Spine Oncology
Study Group. Spine (Phila Pa 1976) 2010 35:E1221–9.
18. Patil CG, Lad SP, Santarelli, Boakye M. National inpatient
complications and outcomes after surgery for spinal metastasis
from 1993–2002. Cancer. 2007;110:625–30.
19. Harel R, Angelov L. Spine metastases: current treatments and
future directions. Eur J Cancer. 2010;46:2696–707.
20. Rades D, Rudat V, Veninga T. A score predicting posttreatment
ambulatory status in patients irradiated for metastatic spinal cord
compression. Int J Radiat Oncol Biol Phys. 2008; 72:905–08.
21. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive
surgical resection in the treatment of spinal cord compression
caused by metastatic cancer: a randomised trial. Lancet.
2005;366(9486):643–8.
2348 A. L. Versteeg et al.
22. Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the
critical perioperative period to improve long-term cancer out-
comes. Nat Rev Clin Oncol. 2015;12:213–26.
23. Donnelly DJ, Abd-El-Barr MM, Lu Y. Minimally invasive
muscle sparing posterior-only approach for lumbar circumferen-
tial decompression and stabilization to treat spine metastasis—
technical report. World Neurosurg. 2015;84:1484–90.
24. Kirshblum SC, Burns SP, Biering-Sorensen F, et al. International
standards for neurological classification of spinal cord injury
(revised 2011). J Spinal Cord Med. 2011;34:535–46.
25. Karnofsky DA, Burchenal JH. The clinical evaluation of
chemotherapeutic agents in cancer. In: Macleod CM, editor.
Evaluation of chemotherapeutic agents. New York: Columbia
University Press; 1949. p. 199–205.
Less Invasive Surgery for Spinal Metastases 2349
